Gefriderm Cutaneous Spray Solution for Dogs
Active ingredients: Ketoconazole, Marbofloxacin, Prednisolone
Form
Spray
Species
Manufacturer
ALPHAVET Zrt.
VMD MA No.
51645/4000
What it's used for
Treatment of acute superficial dermatitis caused by mixed infections with Pseudomonas aeruginosa or susceptible to marbofloxacin and susceptible to ketocon...
Full indications, dosage and side effects ↓The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Ketoconazole + Marbofloxacin...
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Gefriderm Cutaneous Spray Solution for Dogs — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.
Pseudomonas aeruginosa or susceptible to
marbofloxacin and susceptible to ketoconazole. The
indication is limited to focal skin infections (e.g. hot spots, intertrigo, superficial
folliculitis).
Before application of the veterinary medicinal product, the affected area should be
cleaned mechanically or by irrigation taking care to avoid further damage to the skin.
Any excess exudate, hair or debris on the treated area should be carefully removed
prior to application.
Apply 2 pumps of the pump spray bottle per 25 cm
area of affected skin twice
daily for 7 days, up to a maximum of 14 days. Hold the pump spray bottle at a
distance of 10 cm from the affected skin during application.
When spraying from a distance of about 10 cm, 2 pumps (approximately 0.2 ml)
corresponds to a recommended treatment dosage is 8.20 µg of marbofloxacin, 16.33
µg of ketoconazole and 7.4 µg of prednisolone per cm
area of affected skin.
Treatment area(s):
The indication is limited to focal skin infections.
-
. This area of
skin is equivalent to an irregular shape of 5 cm x 5 cm.
-
, the treated area
should be divided into multiple 25 cm
zones. A maximum of 4 treatment areas
may be treated at the same time.
-
surface taking into account size of the dog, age, concomitant diseases and any
other influencing factors.
Revised: January 2025
AN: 02284/2024 + 02940/2024
The length of the treatment period:
Length of treatment depends on the speed of clinical and microbiological healing (i.e.
clinical recovery of bacterial and fungal skin lesions).
-
-
product application should be continued until the 14th day of treatment (see also
section 4.4).
-
lesions should be re-evaluated by the veterinarian. If continued medical treatment
is required, a change to another appropriate veterinary medicinal product is
recommended.
This veterinary medicinal product must not be used exceeding the recommended dose
per administration (0.2 ml/treatment, twice daily) nor beyond a 14-day period.
The used product has to be disposed after finishing the treatment (see also section
6.6).
excipients.
Revised: January 2025
AN: 02284/2024 + 02940/2024
cutaneous application of the active substances.
Revised: January 2025
AN: 02284/2024 + 02940/2024
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
should be used to determine the primary factors involved. The unnecessary use of any
pharmacologically active substance should be avoided.
Treatment is indicated only if mixed infection with
Staphylococcus pseudintermedius
If one of the pharmacologically active substances is no longer indicated due to the
different characteristics of bacterial and fungal infections, the application of
pharmacologically active substance should be discontinued and replaced by an
appropriate treatment option.
The indication is limited to focal skin infections not exceeding 25 cm
. The treatment
is 2 pumps of the application pump to each treated animal when the affected area is
under 25 cm
, and above this value the treated area has to be partitioned 25 cm
zones, maximum 4 treatment areas at the same time. Cross-resistance has been
shown between quinolones. The product should not be used when antimicrobial
susceptibility testing has shown resistance to quinolones because its effectiveness
may be reduced.
Special precautions for use in animals
Animals should be prevented from licking the application site (e.g., by the fixation of a
collar). Keep the animals to be treated separated from each other in order to prevent
licking each other. Use of the veterinary medicinal product should be based on
identification of infecting organisms and susceptibility testing.
Fluoroquinolones should be reserved for the treatment of clinical conditions which
have responded poorly, or are expected to respond poorly to other classes of
antimicrobials. However, microbiological diagnosis and susceptibility test must be
performed. Official and local antimicrobial policies should be taken into account when
the product is used.
Use of the product deviating from the instructions given in the SPC may increase the
prevalence of bacteria resistant to the fluoroquinolones and may reduce effectiveness
of treatment with other quinolones due to the potential for cross-resistance. Heavy
reliance on a single class of antibiotic may result in the induction of resistance in a
bacterial population.
Direct contact of product with eyes must be avoided.
If hypersensitivity to any of the active components occurs, treatment should be
discontinued and appropriate therapy should be initiated.
Prolonged and intensive use of topical corticosteroids preparation is known to trigger
local and systemic effects, including suppression of adrenal function, thinning of the
epidermis and delayed healing.
Spraying on open lesions and wounds must be avoided.
During the administration do not bath or shampoo the animal.
The hair coat should be kept short during treatment to assist optimal contact of
antimicrobial agents with the skin surface. Use only on altered parts of skin.
Revised: January 2025
AN: 02284/2024 + 02940/2024
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This product may be harmful to children after accidental ingestion (gastrointestinal
disturbances, insomnia, and restlessness). Do not leave the bottle out of its child
resistant container except when applying the product to the animal. The bottle must
be closed and placed in the child resistant container immediately after application
and kept in a safe place out of the sight and reach of the children.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Ketoconazole and prednisolone may affect the unborn child and negatively influence
male reproductive functions. Excessive exposure to the product may lead to foetal
defects, or reduced sperm viability. The product should not be administered by
pregnant women, or those trying to conceive.
Marbofloxacin, ketoconazole and prednisolone may cause hypersensitivity (allergy)
reactions. People with known hypersensitivity to (fluoro)quinolones, ketoconazole,
prednisolone, or DMSO should avoid contact with the product.
This product may be irritating to skin and mucosal membranes. Avoid contact with the
skin including hand–to–mouth contact. Wear single-use impermeable gloves when
handling and administering the product. If contact occurs, wash hands or the exposed
area thoroughly with clean water.
Seek medical advice in case of hypersensitivity reactions or if irritation persists.
Swelling of face, lip and eyes, or respiratory difficulties are more serious signs that
need urgent medical action.
This product may be irritating to the eyes. Avoid contact with the eyes including hand-
to eye contact. If contact occurs, rinse with clean water. If eye irritation persists, seek
medical advice and show the package leaflet or label to the physician.
This product may be harmful after inhalation. Spray animals in the open air or in well-
ventilated area. Avoid breathing in the spray-mist.
Do not smoke, drink or eat while handling the product.
Flammable solution. Do not spray on naked flame or any incandescent material.
Avoid prolonged contact with the treated animals. Treated animals should not be
handled and children should not be allowed to play with treated animals until the
application site is dry (at least 20 minutes). It is therefore recommended that animals
are not treated during the day, but should be treated during the early morning and
evening.
Treated animals should not be allowed to sleep with owners, especially children.
Treated areas should not be touched during the treatment period; any fur, or other
areas that do not require this treatment, that may have been sprayed, should be
thoroughly cleaned using a disinfectant wipe to prevent contamination. Any wipes and
gloves used should be disposed of immediately.
activity of marbofloxacin and are to be avoided. No interaction studies have been
provided to confirm acceptability of use of products in combination and so the
safety/efficacy of such combined product use is uncertain.
5.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Related Conditions
Other Products Containing Ketoconazole
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
VetBox Flea & Worm Protection for Dogs
Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Actionis 50 mg/ml, Suspension for Injection for Pigs and Cattle
POM-VCeftiofur
Actionis 50 mg/ml, Suspension for Injection for Pigs and Cattle
POM-VCeftiofur
Adaxio Shampoo for Dogs
POM-VChlorhexidine Gluconate + Miconazole Nitrate
Adaxio Shampoo for Dogs
POM-VChlorhexidine Gluconate + Miconazole Nitrate
Advocin 180, 180 mg/ml, Solution for Injection for Cattle
POM-VDanofloxacin
Aivlosin 42.5 mg/g Oral Powder for Pigs
POM-VTylvalosin
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.